13.1% of XBI Holdings Seeing Recent Insider Buys
November 19, 2014 at 09:50 AM EST
A look at the weighted underlying holdings of the SPDR S&P Biotech ETF (XBI) shows an impressive 13.1% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying ARIAD Pharmaceuticals, Inc.